Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB1148 for Post-Operative Ileus in Elective Bowel Resection
NCT05056935Phase 2Completed
- Sponsor
- Newsoara Biopharma
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of LB1148 in postoperative ileus (POI), sponsored by Newsoara Biopharma. Started Jul 2019; status: completed.
02
Drugs
LB1148
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT05056935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05056935.